MELISSA BROWN: Open Payments
NPI 1013249275 · ENCINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 57 payments from 11 companies in 2025. Trend: 2023 $995 · 2024 $852 · 2025 $1,304
Food & beverage: $1,304
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $369 |
| REVANCE THERAPEUTICS, INC. | 10 | $306 |
| UCB, Inc. | 7 | $258 |
| Janssen Biotech, Inc. | 13 | $173 |
| Galderma Laboratories, L.P. | 1 | $41 |
| Botanix SB Inc | 1 | $33 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $30 |
| Biofrontera Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
Products named: DAXXIFY, Bimzelx, TREMFYA, SKYRIZI, BOTOX, RINVOQ, SOFDRA, COSENTYX.
Industry payments across CA — which companies pay providers there.
